Skip to main content
Medinice S.A. logo

Medinice S.A. — Investor Relations & Filings

Ticker · ICE ISIN · PLMDNCE00016 LEI · 259400LGO9UDV1Y18Z11 WAR Manufacturing
Open in API
Filings indexed 771 across all filing types
Latest filing 2021-10-27 Capital/Financing Update
Country PL Poland
Listing WAR ICE

About Medinice S.A.

https://www.medinice.pl/?lang=2

Medinice S.A. is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions in the fields of cardiology and cardiac surgery. The company's mission is to create patient-focused technologies that improve the quality of life for individuals with cardiac diseases. Its portfolio consists of advanced medical devices, including Class III devices, which undergo a full research, development, and clinical trial process before market introduction. Key projects include CoolCryo, a cryoablation system; AtriClamp, for left atrial appendage closure; and PacePress, a specialized compression band used after cardiac device implantation procedures.

Recent filings

Filing Released Lang Actions
Postanowienie dotyczące dokonania wpisu w KRS o podwyższeniu kapitału w spółce JitMed sp. z o.o. - Content (PL)
Capital/Financing Update Classification · 98% confidence The document text discusses the completion of a previously announced agreement involving the subscription for newly issued shares in a subsidiary (JitMed sp. z o.o.) and the subsequent registration of the capital increase in the National Court Register (KRS). This action directly relates to changes in the company's capital structure and financing activities. The legal basis cited is the regulation concerning current and periodic information disclosed by issuers of securities. This aligns best with the 'Capital/Financing Update' category.
2021-10-27 Polish
Informacja w sprawie umowy dot. nabycia praw do opatentowanych urządzeń kardiochirurgicznych - Content (PL)
M&A Activity Classification · 99% confidence The document text discusses ongoing negotiations ('kontynuują rozmowy') related to the acquisition of rights to medical devices ('Suction Knife' and 'SpaceMaker') following previous announcements (referencing ESPI communications). It explicitly states that the final agreement was not concluded by the specified date (October 15, 2021). This content relates to potential mergers, acquisitions, or significant business transactions. Since it is an update on the status of a potential deal rather than the final agreement or a general regulatory filing, it best fits the M&A Activity category (TAR). Given the short length (1178 chars) and the nature of providing an update on a transaction status, it is not a comprehensive report but a specific announcement regarding M&A progress.
2021-10-18 Polish
Rozpoczęcie ostatniego etapu fazy ostrej badania przedklinicznego w projekcie MiniMax - Content (PL)
Regulatory Filings Classification · 99% confidence The document text is a short announcement (1148 characters) from the Management Board ('Zarząd') of Medinice S.A. It details the commencement of the final preclinical testing phase (acute phase on animals) for a medical device called 'MiniMax' electrode, outlining the objectives (safety and efficacy assessment) and mentioning previous steps (biocompatibility tests). This is not a full financial report (10-K, IR), an earnings release (ER), or a dividend notice (DIV). It describes a significant operational/development milestone related to a product. Since it is a specific operational update that doesn't fit perfectly into the financial categories (like CAP, TAR, SHA), and it's not a standard regulatory filing announcement (RPA/RNS), it best fits under Regulatory Filings (RNS) as a general, material, non-financial operational update, or potentially as a general announcement if a more specific category existed. Given the options, RNS serves as the best general regulatory/material announcement fallback for non-standard operational news.
2021-09-27 Polish
Medinice Raport z przeglądu - jednostkowe
Audit Report / Information Classification · 99% confidence The document is titled "Raport niezależnego biegłego rewidenta z przeglądu śródrocznego skróconego sprawozdania finansowego" (Independent auditor's report on the review of the condensed interim financial statements). It explicitly discusses a 'przegląd' (review) of the 'śródrocznego skróconego sprawozdania finansowego' (condensed interim financial statements) for the period ending June 30, 2021. This content directly relates to the audit/review of financial results for a period shorter than a year. This aligns perfectly with the definition of an Audit Report / Information (AR), which covers standalone audit reports and results of internal/regulatory stress tests, distinguishing it from a full Annual Report (10-K) or a standard Interim Report (IR) which would contain the statements themselves, not just the auditor's review opinion on them. The document is the auditor's opinion on the interim financials. H1 2021
2021-09-08 Polish
Medinice Raport z przeglądu - skonsolidowane
Audit Report / Information Classification · 99% confidence The document is titled "Raport niezależnego biegłego rewidenta z przeglądu śródrocznego skróconego skonsolidowanego sprawozdania finansowego" (Report of the independent auditor on the review of the condensed consolidated interim financial statements). It explicitly details the scope of a 'przegląd' (review) conducted according to International Standard on Review Engagements 2410, covering the period ending June 30, 2021. This document is a formal report from an auditor concerning interim financial statements, which aligns perfectly with the definition of an Audit Report / Information (AR), as it is a standalone audit/review report and not the full Annual Report (10-K) or a general Earnings Release (ER). H1 2021
2021-09-08 Polish
Skonsolidowany Raport za I półrocze 2021 r.
Interim / Quarterly Report Classification · 100% confidence The document is a 'Skonsolidowany Raport Półroczny' (Consolidated Semi-Annual Report) for Medinice S.A. for the first half of 2021. It contains comprehensive financial statements, including the balance sheet, income statement, and cash flow data, as well as management's notes and an audit review report. Since it covers a period shorter than a full fiscal year and contains substantive financial data, it is classified as an Interim/Quarterly Report. H1 2021
2021-09-08 Polish

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.